🎉 M&A multiples are live!
Check it out!

Imeik Technology Development Valuation Multiples

Discover revenue and EBITDA valuation multiples for Imeik Technology Development and similar public comparables like Vivoryon Therapeutics, Julphar, and Armata Pharmaceuticals.

Imeik Technology Development Overview

About Imeik Technology Development

Imeik Technology Development Co Ltd is engaged in research and development, production, and sales of biomedical materials and biopharmaceuticals.


Founded

2004

HQ

China
Employees

1.2K+

Website

imeik.net

Financials

LTM Revenue $397M

LTM EBITDA $283M

EV

$6.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Imeik Technology Development Financials

As of September 2025, Imeik Technology Development reported last 12-month revenue of $397M and EBITDA of $283M.

In the same period, Imeik Technology Development generated $373M in LTM gross profit and $248M in net income.

See Imeik Technology Development valuation multiples based on analyst estimates

Imeik Technology Development P&L

In the most recent fiscal year, Imeik Technology Development reported revenue of $424M and EBITDA of $327M.

Imeik Technology Development expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Imeik Technology Development valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $397M XXX $424M XXX XXX XXX
Gross Profit $373M XXX $402M XXX XXX XXX
Gross Margin 94% XXX 95% XXX XXX XXX
EBITDA $283M XXX $327M XXX XXX XXX
EBITDA Margin 71% XXX 77% XXX XXX XXX
EBIT $285M XXX $303M XXX XXX XXX
EBIT Margin 72% XXX 71% XXX XXX XXX
Net Profit $248M XXX $275M XXX XXX XXX
Net Margin 62% XXX 65% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Imeik Technology Development Stock Performance

Imeik Technology Development has current market cap of CNY 51.3B (or $7.2B), and EV of CNY 48.3B (or $6.8B).

Market Cap Evolution

Imeik Technology Development Stock Data

As of October 17, 2025, Imeik Technology Development's stock price is CNY 170 (or $24).

See Imeik Technology Development trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$6.8B $7.2B XXX XXX XXX XXX $0.83

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Imeik Technology Development Valuation Multiples

Imeik Technology Development's trades at 16.0x EV/Revenue multiple, and 20.7x EV/EBITDA.

See valuation multiples for Imeik Technology Development and 15K+ public comps

Imeik Technology Development Financial Valuation Multiples

As of October 17, 2025, Imeik Technology Development has market cap of $7.2B and EV of $6.8B.

Equity research analysts estimate Imeik Technology Development's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Imeik Technology Development has a P/E ratio of 29.0x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $7.2B XXX $7.2B XXX XXX XXX
EV (current) $6.8B XXX $6.8B XXX XXX XXX
EV/Revenue 17.1x XXX 16.0x XXX XXX XXX
EV/EBITDA 23.9x XXX 20.7x XXX XXX XXX
EV/EBIT 23.8x XXX 22.4x XXX XXX XXX
EV/Gross Profit 18.2x XXX n/a XXX XXX XXX
P/E 29.0x XXX 26.2x XXX XXX XXX
EV/FCF 29.7x XXX 28.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Imeik Technology Development Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Imeik Technology Development Margins & Growth Rates

Imeik Technology Development's last 12 month revenue growth is 11%

Imeik Technology Development's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Imeik Technology Development's rule of 40 is 88% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Imeik Technology Development's rule of X is 100% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Imeik Technology Development and other 15K+ public comps

Imeik Technology Development Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 11% XXX 4% XXX XXX XXX
EBITDA Margin 71% XXX 77% XXX XXX XXX
EBITDA Growth 11% XXX -6% XXX XXX XXX
Rule of 40 88% XXX 88% XXX XXX XXX
Bessemer Rule of X XXX XXX 100% XXX XXX XXX
Revenue per Employee XXX XXX $0.3M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 3% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 10% XXX XXX XXX
Opex to Revenue XXX XXX 23% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Imeik Technology Development Public Comps

See public comps and valuation multiples for Biopharmaceuticals comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Imeik Technology Development M&A and Investment Activity

Imeik Technology Development acquired  XXX companies to date.

Last acquisition by Imeik Technology Development was  XXXXXXXX, XXXXX XXXXX XXXXXX . Imeik Technology Development acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Imeik Technology Development

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Imeik Technology Development

When was Imeik Technology Development founded? Imeik Technology Development was founded in 2004.
Where is Imeik Technology Development headquartered? Imeik Technology Development is headquartered in China.
How many employees does Imeik Technology Development have? As of today, Imeik Technology Development has 1.2K+ employees.
Is Imeik Technology Development publicy listed? Yes, Imeik Technology Development is a public company listed on SHE.
What is the stock symbol of Imeik Technology Development? Imeik Technology Development trades under 300896 ticker.
When did Imeik Technology Development go public? Imeik Technology Development went public in 2020.
Who are competitors of Imeik Technology Development? Similar companies to Imeik Technology Development include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Imeik Technology Development? Imeik Technology Development's current market cap is $7.2B
What is the current revenue of Imeik Technology Development? Imeik Technology Development's last 12 months revenue is $397M.
What is the current revenue growth of Imeik Technology Development? Imeik Technology Development revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Imeik Technology Development? Current revenue multiple of Imeik Technology Development is 17.1x.
Is Imeik Technology Development profitable? Yes, Imeik Technology Development is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Imeik Technology Development? Imeik Technology Development's last 12 months EBITDA is $283M.
What is Imeik Technology Development's EBITDA margin? Imeik Technology Development's last 12 months EBITDA margin is 71%.
What is the current EV/EBITDA multiple of Imeik Technology Development? Current EBITDA multiple of Imeik Technology Development is 23.9x.
What is the current FCF of Imeik Technology Development? Imeik Technology Development's last 12 months FCF is $228M.
What is Imeik Technology Development's FCF margin? Imeik Technology Development's last 12 months FCF margin is 57%.
What is the current EV/FCF multiple of Imeik Technology Development? Current FCF multiple of Imeik Technology Development is 29.7x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.